Regulus Therapeutics Inc (RGLS)
2.495
+0.20
(+8.48%)
USD |
NASDAQ |
May 01, 16:00
2.51
+0.02
(+0.60%)
After-Hours: 20:00
Regulus Therapeutics Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2020 | 4.652M |
September 30, 2020 | 13.65M |
June 30, 2020 | 14.64M |
March 31, 2020 | 14.64M |
December 31, 2019 | 14.63M |
September 30, 2019 | 14.63M |
June 30, 2019 | 14.62M |
March 31, 2019 | 15.22M |
December 31, 2018 | 16.58M |
September 30, 2018 | 19.07M |
June 30, 2018 | 19.89M |
March 31, 2018 | 19.87M |
December 31, 2017 | 19.86M |
September 30, 2017 | 19.84M |
June 30, 2017 | 19.83M |
March 31, 2017 | 19.82M |
December 31, 2016 | 19.80M |
September 30, 2016 | 19.79M |
June 30, 2016 | 19.79M |
Date | Value |
---|---|
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 23.40M |
September 30, 2014 | 10.66M |
June 30, 2014 | 12.45M |
March 31, 2014 | 13.40M |
December 31, 2013 | 11.28M |
September 30, 2013 | 13.92M |
June 30, 2013 | 14.59M |
March 31, 2013 | 11.90M |
December 31, 2012 | 10.13M |
September 30, 2012 | 17.07M |
June 30, 2012 | 5.00M |
March 31, 2012 | 0.00 |
December 31, 2011 | 10.00M |
September 30, 2011 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
4.652M
Minimum
Dec 2020
14.64M
Maximum
Jun 2020
13.06M
Average
14.63M
Median
Sep 2019
Total Long Term Debt (Quarterly) Benchmarks
ACADIA Pharmaceuticals Inc | 0.00 |
ADMA Biologics Inc | 130.59M |
FibroGen Inc | 71.93M |
Protara Therapeutics Inc | -- |
Amylyx Pharmaceuticals Inc | 0.00 |